Cheryl Pegus insider trades: Boston Scientific (BSX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Cheryl reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | BSX | ↑ Buy | 1,770 | $56.49 | $100K | Direct | May 21, 2026 (1d) |
| Dec 17, 2020 | PHR | ↓ Sell | 31,147 | $55.91 | $1.7M | Direct | Dec 18, 2020 (1d) |
| Dec 17, 2019 | PHR | ↓ Sell | 500,000 | $24.48 | $12.2M | By Echo Health Ventures LLC | Dec 18, 2019 (1d) |
| Jul 22, 2019 | PHR | ↓ Sell | 280,689 | $18.00 | $5.1M | By Echo Health Ventures LLC | Jul 24, 2019 (2d) |
| Dec 12, 2017 | TCMD | ↑ Buy | 1,000 | $27.86 | $28K | Direct | Dec 14, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BSX insiders
Open-market trades in the last 12 months
About Cheryl Pegus's insider trades
Cheryl Pegus is a director at Boston Scientific (BSX). Since Dec 12, 2017, Cheryl has reported 2 open-market purchases worth $128K and 3 sales worth $19.0M on SEC Form 4. In the last 12 months: 1 buy ($100K).
Their filings also include grants and awards (22 filings), shares withheld for taxes (1 filing), option exercises (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BSX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.